A retrospective, single center, observational study assessing the difference in terms of absolute eosinophil count (AEC) change at 4 months and at 12 months as compared to the baseline in patients with moderate-to-severe Atopic Dermatitis treated with Dupilumab
Latest Information Update: 29 Aug 2022
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
Most Recent Events
- 29 Aug 2022 New trial record
- 01 Aug 2022 Results published in the Journal of Dermatological Treatment